Thanks BF.
That is a lingering question for me. A bit like another stock I am holding who are front runners in a technology (graphene) but requires technical pull through and time to assess in field studies before clients commit to $$ benefit.
The trials you speak of, have they finalised and shown publsihed client agreed economic benefit or still in motion? If finalised, is there a link to the publication please?
Cheers
Ann: Indago Makes Sales of Multi-Flow in Texas, page-21
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.425M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 65188 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 2962937 | 3 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| HCD (ASX) Chart |
Day chart unavailable